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INTRODUCTION
Implants can be the culprit of biomaterial-associated infec-
tions depending on the location and implantation of the bio-
material in the body. These infections are known to be diffi-
cult to treat and implants are subsequently removed in order
to avoid life-threatening complications. Biomaterial-
associated infections are often linked to additional surger-
ies, which may lead to increased patient discomfort and ex-
penses (Gristina, 1987).
There are several ways how bacteria can infect biomaterials.
Biomaterials can be infected by patients’ microbiota of the
skin and mucous membranes or that of the surgeon, as well
as bacteria present in the air microbiota of operating thea-
tres, where levels of bacteria are up to 20–60 CFU·m-3. An-
other possible route of infection is via the bloodstream from
sites of infection in other parts of the body following sur-
gery (Hughes and Anderson, 1999; McCann et al., 2008;
Hodgson et al., 2014).
Due to the fact that implantation of biomaterials inherently
entails trauma to tissue, bacterial contamination of the im-
plant can cause significant production of inflammatory
cytokines, or the opposite, its suppression. Inflammatory
cytokines (TNF-, IL-6 and procalcitonin) are promising
laboratory markers for evaluating the intensity of inflamma-
tion (Bottner et al., 2007).
Some authors recommend the use of inflammatory cyto-
kines TNF-, IL-1, IL-8, to assess the dynamics of the de-
velopment of inflammation following implantation. If the
level of inflammatory cytokines does not decrease within
seven days following surgery, this could indicate infection
of the implant (Shindo et al., 2003). Staphylococcus
epidermidis (which is part of the skin microbiota) can cause
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Local antibiotic therapy has several advantages over systemic antibiotic treatment. Using antibiot-
ics in local biomaterial systems can reduce the number of microorganisms that can adhere to im-
planted biomaterials. In this in vitro study, antibacterial properties of hydroxyapatite biomaterials
impregnated with antibiotics and biodegradable polymers were examined. The antibacterial effi-
ciency of hydroxyapatite biomaterials impregnated with antibiotics and biodegradable polymers
against Staphylococcus epidermidis and Pseudomonas aeruginosa was studied by evaluating the
expression of inflammatory cytokines (Interleukin-10 (IL-10), -defensin-2 and tumour necrosis
factor alpha (TNF-)) in tissue surrounding implanted biomaterials in vivo. The results of this
study demonstrated that hydroxyapatite biomaterials impregnated with antibiotics and biodegrad-
able polymers had a prolonged antibacterial effect in comparison to biomaterials without biode-
gradable polymers. Surrounding tissue displayed higher levels of inflammatory cytokines when
implanted biomaterials had not been previously impregnated with antibiotics.
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biomaterial-associated infections. An important characteris-
tic of S. epidermidis is its ability to induce beta-defensin
production. Increased -defensin-2 levels generally show
activity against Gram-negative bacteria, and -defensin-3
shows activity against both Gram-positive (Staphylococcus
aureus) and against Gram-negative bacteria (Pseudomonas
aeruginosa) (Sawamura et al., 2005).
IL-10 is an anti-inflammatory cytokine, which reduces the
expression of other cytokines, such as TNF-alpha, IL-6 and
IL-1. IL-10 promotes the secretion of other anti-inflam-
matory cytokines, and reduces the quantity of inflammatory
cytokine receptors (Zhang and Jianxiong, 2007). IL-10 in-
hibits activation of T cells, monocytes and macrophages. Its
main function is the reduction and termination of the in-
flammatory reaction (Moore et al., 2001). IL-10 is secreted
by Th2 cells and T regulatory cells, which activate B cell
growth and inhibit Th1 responses (Rousset et al., 1992).
The principal aim of this study was to compare the antibac-
terial efficiency of hydroxyapatite (HAp) saturated with
ciprofloxacin (cipro) and polyL-lactic acid (PLLA) polymer
with a controlled release of antibiotics with HAp saturated
with cipro without PLLA. Another aim was to evaluate the
expression of inflammatory cytokines (IL-10, -defensin-2
and TNF-alpha) in tissue surrounding implanted bio-
materials in vivo.
MATERIALS AND METHODS
Procedure of HAp/PLLA+cipro sample synthesis. HAp
powder was prepared using the wet chemical precipitation
synthesis method from calcium oxide (CaO, Fluka,  97%)
and orthophosphoric acid solution (Sigma-Aldrich,  85%)
(Sokolova et al., 2014). The as-synthesised powders ob-
tained were uniaxial, pressed into pellets (d = 10, h = 3
mm). All samples were sintered at 1100 °C for one hour.
In order to load drugs in the HAp scaffolds, cipro was dis-
solved in deionised water at a concentration of 10 mg·ml-1.
The scaffolds were impregnated with 2 ml aqueous drug so-
lution at room temperature, followed by drying at 37 °C.
Some of the prepared samples were used for coating with
PLLA.
Solution of 10 wt% PLLA (Nature Works LLC, Mw = 110
kDa) in dichloromethane (DCM) (Sigma-Aldrich, UK) was
prepared to coat the HAp scaffolds with polymer. PLLA
was dissolved in DCM by stirring it for 2 hours at room
temperature. Polymer solution was infiltrated in HAp bioce-
ramic scaffolds using the vacuum impregnation technique at
500 mbar pressure for 15 minutes. Coated scaffolds were
dried at room temperature for 24 hours.
The open (P0) porosity and total (Pt) porosity of scaffolds
were determined by the Archimedes method based on the
principle that buoyant force is equal to the weight of the
fluid displaced (Locs et al., 2013). Observations of the
cross-section microstructure of coated scaffolds by SEM re-
vealed that HAp/PLLA scaffolds coated with 10 wt% of
PLLA exhibited a porous microstructure with pore size esti-
mated to be in the range 200 nm to 500 nm (Fig. 1).
Antibacterial efficiency of HAp/PLLA+Cipro samples
by disk diffusion method. Antibacterial efficiency was
tested via the disk diffusion test (also called Kirby–Bauer
method), which is the standard laboratory method for test-
ing antibacterial susceptibility.
HAp/PLLA+cipro, HAp+cipro and HAp/PLLA disks were
first eluted in rabbit blood plasma at 37 °C with 5% CO2 at-
mosphere and 100% relative humidity for two hours. Then
bacterial suspension with optical density 0.5 was prepared
according to the McFarland standard. Trypticase soy agar
(TSA) (Oxoid, UK) plates were inoculated with 100 µl of
the bacterial suspension. The agar plates were inoculated
using the streak plate method with a swab containing the in-
oculum. The plates were rotated and the inoculation proce-
dure was repeated until the distribution of the inoculum was
even. Biomaterial discs were placed on the plates and incu-
bated for 24 hours at 37 °C. Antibacterial properties were
detected by measuring a sterile zone (diameter) around the
biomaterial discs. Biomaterial discs were transferred on
fresh TSA plates with bacterial inoculum, and were incu-
bated for an additional 24 hours. Repeated measurements
Fig. 1. SEM micrographs of HAp/PLLA
coated scaffolds cross-section. A, pore di-
ameter in the range 200 nm to 500 nm; B,
PLLA coating of 2–5 µm in thickness.
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and fresh TSA late inocula were made every 24 hours until
no antibacterial properties were detected on any of the bio-
material samples for two consecutive days. Antibacterial ef-
ficiency was also tested with this method for HAp+cipro
and HAp/PLLA samples.
Animal model. Chinchilla rabbits (n = 9) were used in this
study for the determination of levels of IL-10, beta-
defensin-2 and TNF-alpha in tissues around implanted bio-
material samples. All the male rabbits weighed 3 kg and
were 3 months old. The in vivo study was approved by the
Food and Veterinary Service of Latvia and the Ministry of
Agriculture of the Republic of Latvia.
Prior to the surgery, we prepared bacterial suspensions of P.
aeruginosa and S. epidermidis with an optical density of 0.5
according to the McFarland standard. The fur on the back
under the scapulae was shaved and the area was sterilised
with iodine solution. A 2.5 cm incision of the skin with a
sterile scalpel and a sufficiently large subcutaneous pocket
(where biomaterial disc could be implanted) was made un-
der local anaesthesia with 2% lidocaine solution. After bio-
material implantation in the subcutaneous pocket, the
wound was infected with 0.1 ml of the bacterial suspension;
the wound was closed with a separate suture. HAp/PLLA+
cipro, HAp+cipro, HAp/PLLA were contaminated with S.
epidermidis or P. aeruginosa. Four weeks later, using stan-
dard ELISA kits (USCN life science and MyBioSource,
USA) according to the manufacturer’s instructions, the lev-
els of IL-10, TNF-alpha and beta-defensin-2 were deter-
mined in the surrounding tissue (internal and external zone)
around the biomaterial and in tissue within a distance of 1.5
cm from the biomaterial. The tissue samples were homoge-
nised with PBS (pH 7.2–7.5) and centrifuged for 5 minutes
at 5000× g. The supernatant was removed immediately.
Bacterial cultures. Antibacterial efficiency of all biomate-
rials was tested using S. epidermidis (ATCC 12228) and P.
aeruginosa (ATCC 27853) bacteria reference cultures,
which were acquired from the American type culture collec-
tion.
Statistical analysis. The results were analysed by non-
parametric statistics. The Mann–Whitney test was used to
test for statistically significant differences between duration
of antibacterial effect of different biomaterial samples. Sta-
tistically significance was assumed if the p value was less
than or equal to 0.05. Statistical analysis was performed
with SPSS 22.0.
RESULTS
Antibacterial efficiency in vitro. The antibacterial effi-
ciency test showed that the period of antibacterial effect of
HAp/PLLA+cipro against S. epidermidis was significantly
longer (p < 0.001) compared to that of HAp+cipro. The pe-
riod of the antibacterial effect against P. aeruginosa for
HAp/PLLA+cipro compared to HAp+cipro was signifi-
cantly longer (p < 0.001). The mean antibacterial time of
HAp/PLLA+cipro samples against S. epidermidis was 278.4
hours, whereas for HAp+Cipro it was 91.2 hours (Fig. 2).
Antibacterial time against P. aeruginosa for HAp/PLLA+
cipro and HAp+cipro was shorter compared to the antibac-
terial time against S. epidermidis, respectively 249.6 hours
for HAp/PLLA+cipro and 69.6 hours for HAp+cipro.
Within the first three days of the study, HAp+cipro com-
pared to HAp/PLLA+cipro showed a larger sterile zone
against S. epidermidis (Fig. 3), which means that HAp+ci-
pro released more antibiotics than HAp/PLLA+cipro.
Within the first two days of the study, HAp+cipro showed
an even larger sterile zone against P.aeruginosa (Fig. 4).
HAp/PLLA+cipro gradually released antibiotics against
both bacterial cultures, and gradually lost antibacterial prop-
erties against S. epidermidis and P. aeruginosa.
No antibacterial properties were observed for HAp/PLLA
samples against both bacterial cultures.
Expression intensity of IL-10 in the animal model. The
highest expression of IL-10 was observed in tissues around
HAp/PLLA. There were no statistically significant (p >
0.05) differences of intensity of IL-10 in direct contact tis-
sues (internal and external zone) and distance zone tissues
compared to the control group, when HAp/PLLA+cipro or
HAp+cipro were implanted and contaminated with S. epi-
dermidis (Fig. 5) or P. aeruginosa (Fig. 6).
Fig. 2. Antibacterial efficiency testing in vi-
tro of Hap/PLLA+cipro (n = 5), Hap+cipro
(n = 5) and Hap/PLLA (n = 5) against S.
epidermidis and P. aeruginosa. Data pre-
sented as mean antibacterial time ± SD.
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A significant (p < 0.001) increase of IL-10 compared to the
control group was expressed in direct contact tissues when
HAp/PLLA was implanted and contaminated with S. epi-
dermidis or P. aeruginosa. The level of IL-10 decreased
significantly (p < 0.001) from direct contact zone tissues to
distance zone tissues, which means that the inflammatory
zone became smaller.
Fig. 3. The dynamics of S. epidermidis growth inhi-
bition. Data presented as mean diameter (mm) of
the sterile zone around Hap/PLLA+cipro or Hap+
cipro disks.
Fig. 4. The dynamics of P. aeruginosa growth inhi-
bition. Data presented as mean diameter (mm) of
the sterile zone around Hap/PLLA+cipro or Hap+
cipro disks.
Fig. 5. The levels of IL-10 in wound tissues contaminated with S.
epidermidis after Hap/PLLA (n = 3), Hap/PLLA+cipro (n = 3) or
Hap+cipro (n = 3) implantation. The level of IL-10 was measured 4 weeks
following implantation. Data presented as mean ± SD.
Fig. 6. The levels of IL-10 in wound tissues contaminated with
P.aeruginosa after Hap/PLLA (n=3), Hap/PLLA+cipro (n=3) or
Hap+cipro (n = 3) implantation. The level of IL-10 was measured 4 weeks
following implantation. Data presented as mean ± SD.
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Expression intensity of TNF-alpha in the animal model.
When composite materials with antibiotics (HAp/PLLA+ci-
pro and HAp+cipro) were implanted and contaminated with
S. epidermidis (Fig. 7) or P. aeruginosa (Fig. 8) the level of
TNF-alpha intensity in tissue did not show any significant
(p > 0.05) differences compared to the control group. The
most intensive TNF-alpha expression was observed in direct
contact tissues around HAp/PLLA for both bacterial cul-
tures and its expression was significantly more intense (p <
0.001) than in the control group.
Expression intensity of -defensin-2 in the animal
model. The most intensive -defensin-2 expression oc-
curred in tissues that were in close contact with HAp/PLLA
and were contaminated with S. epidermidis (Fig. 9).
-defensin-2 levels significantly differed (p < 0.05) between
treatments and the control group. Between the external and
internal tissue zones, there were no significant differences
(p > 0.05).
We observed significant (p < 0.05) differences in
-defensin-2 intensity levels between the direct contact
zone tissues and the distanced zone tissues of the
HAp/PLLA, which means that over time beta-defensin-2 in-
tensity reduced. The level of -defensin-2 did not change
after implantation of composite materials with antibiotics.
In comparison to the control group, no difference in expres-
sion of -defensin-2 wa observed after HAp/PLLA+cipro
and HAp+cipro implantation and contamination with P.
aeruginosa (Fig. 10). The highest expression in
Fig. 7. The levels of TNF-alpha in wound tissues contaminated with S.
epidermidis after Hap/PLLA (n = 3), Hap/PLLA+cipro (n = 3) or
Hap+cipro (n = 3) implantation. The level of TNF-alpha was measured 4
weeks following implantation. Data presented as mean ± SD.
Fig. 8. The levels of TNF-alpha in wound tissues contaminated with P.
aeruginosa after Hap/PLLA (n = 3), Hap/PLLA+cipro (n = 3) or
Hap+cipro (n = 3) implantation. The level of TNF-alpha was measured 4
weeks following implantation. Data presented as mean ± SD.
Fig. 9. The levels of beta-defensin-2 in wound tissues contaminated with S.
epidermidis after Hap/PLLA (n = 3), Hap/PLLA+cipro (n = 3) or
Hap+cipro (n = 3) implantation. The level of beta-defensin-2 was mea-
sured 4 weeks following implantation. Data presented as mean ± SD.
Fig. 10. The levels of -defensin-2 in wound tissues contaminated with P.
aeruginosa after Hap/PLLA (n = 3), Hap/PLLA+cipro (n = 3) or
Hap+cipro (n = 3) implantation. The level of beta-defensin-2was measured
4 weeks following implantation. Data presented as mean ± SD.
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-defensin-2 was observed after HAp/PLLA implantation.
The most intensive -defensin-2 expression was observed in
direct contact zone tissues around HAp/PLLA. The inten-
sity level of -defensin-2 was significantly (p < 0.05) lower
in distant tissues compared to the direct contact zone, but
there were no significant (p > 0.05) differences between the
level of -defensin-2 in the distant tissue zone and the con-
trol group.
DISCUSSION
The widespread use of biomaterials is often associated with
unwanted effects, e.g. bacterial contamination and biofilm
formation. In this study, newly synthesised biomaterials
were impregnated with antibiotics in order to avoid these
unwanted effects. The in vitro study showed that such an
approach is promising and bacterial adhesion and colonisa-
tion of biomaterial surfaces is significantly inhibited. In this
study we modelled infection in vivo and evaluated the level
of inflammatory cytokines and antibacterial peptides.
Biofilms can form on implanted biomaterials after contami-
nation of biomaterials with S. epidermidis and P. aerugi-
nosa. Biofilms can protect bacteria from antibiotic sub-
stances and immune cells; thereby impeding the treatment
process of biomaterial-associated infections (Aybar et al.,
2012; Drenkard, 2013; Vassena et al., 2014). Thus, antibiot-
ics can be used to prevent biofilm formation on biomaterials
prior to adhesion and colonisation of bacteria. Higher con-
centration of antibiotics is achieved if antibiotics are used
locally at the site of biomaterial implantation. Combining
local, long-term and controlled release of antibiotics from
biomaterials may reduce contamination risk, which in turn
contributes to faster patient recovery (Hanssen, 2005; An-
toci et al., 2008).
In this study, HAp/PLLA+cipro showed good antibacterial
properties against S. epidermidis and P. aeruginosa and in
comparison to HAp+cipro, as it showed controlled and
gradual release of antibiotics from the biomaterial for a
longer period of time. Because of differences in the bacte-
rial cell wall structure (S. epidermidis and P. aeruginosa),
the chosen antibiotics must be able to kill both bacterial cul-
tures. The experimental data of this study are similar to
other authors’ studies, which achieved controlled release of
antibiotics from biomaterials for longer periods of time us-
ing biodegradable polymer coatings (Li et al., 2011; Guil-
laume et al., 2012). For example, antibacterial properties
were observed up to 14 days, depending on the type of
polymer used in the study. Antibacterial properties lasted
for an average of 240 hours, reaching even 264 hours of ac-
tivity if PLLA were used (Kroica et al., 2016). The antibac-
terial properties of these biomaterials were studied using the
most common causative agents of biomaterial-associated in-
fections. The choices of antibiotics in these studies varied,
but there were common features such as the ability to kill
various bacterial cultures (Chai et al., 2007; Guo et al.,
2013; Lyndon and Birbilis, 2014).
The level of inflammatory cytokines and -defensin-2 in
surrounding tissue after HAp/PLLA+cipro, HAp+cipro and
HAp/PLLA implantation and contamination with bacterial
cultures (S. epidermidis and P. aeruginosa) were deter-
mined in an in vivo study.
High expression of IL-10 was detected in tissue surrounding
the implanted biomaterials, which persisted up to 21 days
following implantation (Gretzer et al., 2006). There is evi-
dence of a difference between IL-10 production in tissue
around the non-toxic (TiO2 based biomaterials) and toxic
(copper based biomaterials) implants. In both cases, the dy-
namics of IL-10 production are similar (Suska et al., 2005).
The difference is observed between biomaterial samples
with and without bacterial contamination. Expression of
IL-10 is lower around tissue samples without bacterial con-
tamination (Duarte et al., 2009).
TNF- is the most accurate cytokine, which can show the
intensity and dynamics of inflammation (Gul et al., 2010).
The presence of TNF- in synovial fluid may indicate de-
velopment of an implant-associated infection (Gollwitzer et
al., 2013).
The release of -defensin-2 is stimulated by inflammatory
cytokines: TNF- and IL-1, and P. aeruginosa (Harder et
al., 2001; Lai et al., 2010; Skadins et al., 2017). Beta-
defensin-2 is also active against S. epidermidis, a represen-
tative of the normal microbiota (Lai et al., 2010). We also
observed elevated levels of inflammatory cytokines and
beta-defensin-2 in our study on biomaterial implantation
with and without bacterial contamination.
In comparison to the control group, no differences were
found in the expression of IL-10, TNF- and -defensin-2
after HAp/PLLA+cipro, HAp+cipro and HAp/PLLA im-
plantation and contamination with S. epidermidis or P.
aeruginosa. Antibiotics in biomaterials ensured the killing
of bacteria, thus preventing the inflammation process.
We observed increased levels of IL-10, TNF- and
-defensin-2 after HAp/PLLA implantation, which clearly
showed an active and strong inflammatory process. The re-
sults showed that the inflammatory process was localised
and developed not only in the surrounding tissue around the
biomaterials, but also spread from the site of biomaterial
implantation. The high expression of cytokines was a result
of the immune response against bacterial infection after
HAp/PLLA implantation; in this case Hap/PLLA did not
contain antibiotics that inhibited bacteria (Schutte et al.,
2009; Sun et al., 2010).
CONCLUSION
Biomaterials with ciprofloxacin and PLLA polymer coating
exhibit antibacterial effects longer against both bacterial
cultures. A biodegradable coating ensures the gradual re-
lease of ciprofloxacin from the biomaterial. Without a bio-
degradable coating, ciprofloxacin is rapidly released from
the biomaterial. An increased level of inflammatory
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cytokines (IL-10, -defensin-2, TNF-) compared to the
control group indicates an active inflammatory process after
HAp/PLLA implantation and contamination with bacterial
cultures. The practical use of biomaterials impregnated with
antibiotics may reduce the expression of inflammatory
cytokines in tissue surrounding implanted devices.
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BIOMATERIÂLU AR ANTIBIOTISKAJÂM VIELÂM IETEKME UZ IEKAISUMA CITOKÎNIEM
Lokâlai antibiotisko vielu terapijai piemît vairâkas priekðrocîbas, salîdzinot ar sistçmisku ârstçðanu. Ðîs priekðrocîbas var izmantot lokâlu
biomateriâlu lietoðanâ, lai samazinâtu to mikroorganismu skaitu, kas piesaistâs pie implanta. Ðajâ in vitro pçtîjumâ mçs pçtîjâm
antibakteriâlâs îpaðîbas hidroksiapatîta biomateriâliem ar antibiotiskajâm vielâm un bionoârdoðu polimçru. Antibakteriâlâs îpaðîbas tika
pçtîtas pret Staphylococcus epidermidis and Pseudomonas aeruginosa baktçrijâm. In vivo pçtîjumâ tika noteikts iekaisuma citokînu lîmenis
(Interleikîns-10 (IL-10), beta-defensîns-2 and tumora nekrotizçjoðais factors alfa (TNF-alpha)) apkârtçjos audos ap biomateriâlu. Ðajâ
pçtîjumâ tika atrasts, ka biomateriâliem ar bionoârdoðos polimçru ir ilgâkas antibakteriâlas îpaðîbas nekâ biomateriâliem bez bionoârdoða
polimçra. Ja tika implantçts biomateriâls bez antibiotiskajâm vielâm, in vivo pçtîjumâ apkârtçjos audos tika atrasts augstâks iekaisuma
citokînu lîmenis, salîdzinot ar kontroles grupu.
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